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INTRODUCTION

Rhodanese (E.C. 2.8.1.1, thiosulfate:cyanide sulfur transferase)
is a mitochondrial enzyme which catalyzes the conversion of cyanide ion
into thiocyanate.

The overall reaction, with thiosulfate as sulfur donor,

is as follows:

+

s

0:::::

so:::

rhodanese

2 3

3

cyanide + thiosulfate

+

SCN

sulfite + thiocyanate

Because of its ability to catalyze the detoxification of cyanide,
rhodanese plays a critical role in the mechanism of action of the proposed anti-cancer drug laetrile, as postulated by Krebs (1970).

Accord-

ing to the Krebs hypothesis, when laetrile enters the body, much of it
is excreted unchanged.

However, a fraction of it is hydrolyzed by the

lysosomal enzyme beta-glucosidase into three products as follows:

N

,....\-\

6('0-~o-e

~

+

laetrile

beta-glucosidase
::;::::>"

water

5

HCN

I

benzaldehyde

+

glucose

+

hydrocyanic acid

When the HCN is released, rhodanese is thought to act upon the HCN, detoxifying it before it is able to inhibit aerobic respiration.

2

Krebs has hypothesized that beta-glucosidase is present in all
tissues of the body.

Rhodanese activity, however, is proposed to be

present only in normal body tissues.

This is because Krebs has proposed

that neoplastic tissue produces chorionic gonadotropin, which he states
inhibits the rhodanese activity in this tissue (1977).
sue, therefore, lacks rhodanese activity.

Neoplastic tis-

As a result, Krebs believes

that when laetrile contacts the neoplastic tissue, the beta-glucosidase
present catalyzes the production of HCN, which the cancer cells are then
unable to act upon because they lack r?odanese.

v ~oplastic

tissue,

therefore, is selectively attacked by laetrile.
In order to test the Krebs hypothesis, the presence of rhodanese
in neoplastic tissue was investigated.

Selected tissues in tumor-

bearing mice as well as the corresponding tissues in normal control
mice were also studied for rhodanese activity.

These tissues were then

compared to each other and to neoplastic tissue for significant differences in rhodanese activity levels.
This paper presents the results of these investigations and a
discussion of the findings as they relate to the Krebs hypothesis.

REVIEW OF THE LITERATURE
In 1933 Konrad Lang first discovered an enzyme in animal

tiss~e

capable of converting colloidal sulfur or thiosulfate and cyanide to
thiocyanate.

He called this enzyme rhodanese because it synthesizes

rhodanate (thiocyanate).

He determined that the reaction proceeded

according to the following equation;

+

7

+

w=
3

Lang used a colorimetric assay technique and surveyed a substantial
number of mammalian, avian, and frog tissues for rhodanese activity.
He was also able to effect a 20-fold purification of oeef-liver
rhodanese.
Rhodanese has been the subject of much investigation since
Lang's original work, and the specific action of rhodanese can now be
described as follows:
free rhodanese

+

sulfane-containing anion

sulfur-substituted rhodanese

+ thiophilic anion
(Westley, 1973)

Free rhodanese molecules react with sulfane-containing anions to form
the sulfur-substituted rhodanese which, in turn, reacts with highly
thiophilic anions to transfer a sulfur atom.
3

4

For twenty years it was generally believed that rhodanese was
specific for thiosulfate and cyanide as substrates.

Then in 1953

Sorbo investigated the possibility of other sulfur-containing compounds serving as sulfur donors.

He concluded that rhodanese can

utilize thiosulfonates that contain a . free thiol group.

For example,

s-so2-o
thiosulfate

p-toluene
thiosulfonate

ethyl thiosulfonate
(Sorbo, 1953)
')

Thiosulfate and para-toluene thiosulfonate both contain free thiol
groups, but since ethyl thiosulfonate does not, it cannot serve as a
substrate.

Sorbo showed that thiosulfonates of the form:
0

l

R---s----s

II
0

can serve with cyanide as a sulfur donor (19531..

He also demonstrated

that,
The activity of the thiosulfonate is roughly correlated to
the electropositivity of the radical attached to the hexavalent sulfur atom, as the activity is increased when the
hydroxyl group in the thiosulfate is replaced by an aromatic
radical and further increased when instead an aliphatic radical is introduced.
(Sorbo, 1953}

Parker and Kharasch (19591 have shown that compounds containing
at least one sulfur-sulfur bond at the sulfenyl (-S-) level of oxidation are suitable as sulfur-donor substrates of rhodanese as long as

5

the donor sulfur atom is not bonded to atoms other than sulfur of
hydrogen.

With this requirement met, polysulfides, persulfides, thio-

sulfonates and thiosulfate can all serve as sulfur-donor substrates
(Westley, 1973).
In a sophisticated series of articles by Westley and his coworkers from 1961 to 1974, the mechanism of action of rhodanese was
investigated and described.

They demonstrated that the rhodanese re-

.. ~tion proceeds via a double displacement mechanism in which the enter-

~tt ~

.

ing nucleophile and the leaving group ' are aligned on opposite sides of
the transferred sulfur atom.
Enzyme

Enzyme-s

2 sso

+

2

+

3

Optimum pH is 8.6.

,1___, Enzyme-s
2
7

2 CN -.L./_ _ _.., Enzyme

7

+
+

2 SCN-

(Green and Westley, 1965)
From their findings they concluded that a cationic binding site (Mintel
and Westley, 1966) and a hydrophobic region composed of seven amino
acids of cysteinyl and tryptophanyl residues were present at the active
site (DeToma and

~'lestley,

1970),

They demonstrated that the sulfur-

sulfur bond cleavage is facilitated by a shift of electrons away from
the planetary sulfur atom, thereby creating a nucleophilic center on the
sulfur-donor compound (Mintel and Westley, 1966).

This explained the

importance of the cationic or nucleophilic residue at the active site of
rhodanese.

Schlesinger and Westley have concluded (19741 that when

rhodanese and thiosulfate interact, they form a complex that results in
charge neutralization and a shift of electrons away from the planetary

6

sulfur on the thiosulfate.

The resulting sulfite is then displaced by

the enzymic nucleophilic group.
and Westley, 1960.)

This is the rate-limiting step.

(Mintel

Apparently the displacing nucleophile is the sulf-

hydryl group on the essential cysteine (Schlesinger and Westley, 1974).
The sulfur-substituted rhodanese then reacts rapidly with the thiophilic
anion acceptor (eg. cyanide) and forms the product (eg. thiocyanate) and
the free enzyme.

The sulfur-substituted enzyme can also react with

thiocyanate to form an unreactive "dead end" complex (Volini and Westley,
1966}.
Sulfur-acceptor substrates have been studied by several workers
including Koj (19681, and others CVillarejo and Westley, 1963, Mintel
and Westley, 1966}

1

The sulfur-acceptor substrates have been widely

accepted to follow a thiophilicity series rnucleophilicity for sulfur}
according to reactivity.

It can be seen that how well the attacking

nucleophile can polarize determines the reaction properties.

A typical

thiophilicity series is as follows:

(Westley, 1973)_

Rhodanese has also been observed to catalyze the reduction of thiosulfate to sulfite using borohydride, dihydrolipoate, cysteine, and
glutathione with the relative activity decreasing in the order given,
with none being as reactive as cyanide (Koj, 1968).

Alkyl and aryl

sulfinates (RS0 ) were later found to be active acceptor substrates
2

7

(Sorbo, 1962).

Apparently nearly any thiosulfonate-sulfinite pair can

function as rhodanese substrates.

A few exceptions do exist, however.

Volini and Westley found that:
Dithiols which oxidize to cyclic disulfides having more than
five ring members (i.e., larger than the dithiolane ring of
oxidized lipoate) do not seem to be active substrates. Both
dithiothreitol and dithioerythrytol fail to yield measureable
rates. In fact, both of these compounds rapidly inactivate
rhodanese.
(Westley, 1973)
Other compounds have also been determined to be inhibitors or
inactivators of rhodanese and have been extremely important in determining the structure of the active site.

In Lang's original article

(1933)_ he describes the inhibiting effect of divalent cations.

Late:t:

Saunders and Himwich (1950} studied their effect in detail and showed
that cu++ and Fe++ are strong inhibitors but that others, including
Mn++ , Si++ , ca++ , Li++ , Mg++ , and Ba++ have little or no effect.
They also demonstrated the inhibiting effects of sodium sulfide,
cysteine, and iodoacetate.

The inhibitory effects of CN- were also

studied independently by Sorbo (19621.

CN

and so 3

=

can markedly in-

hibit rhodanese activity, but in the presence of cysteine or thiosulfate, inhibition is prevented.

Sorbo (19531 also showed that thio-

cyanate, too, can inhibit rhodanese activity if it is in too high of a
concentration.

However, thiosulfate has been shown to significantly
'

reduce the sensitivity of rhodanese to many inactivating and inhibiting
reagents.

But this sensitivity also depends upon other factors, includ-

ing oxygen and protein concentrations (Westley, 1973}.

Dithiothreitol

8

causes complete inactivation of rhodanese.

Kim and Horowitz (1975)_

suggest that it binds to the essential sulfhydryl group.

Dinitrobenzene

(Volini and Wang, 1973), N-ethylmaleimide, and mercuribenzoate are inhibitors first described by Sate and Hayashi (1952}.

Since then, other

thiol-directing reagents have been shown to inhibit rhodanese function.
When a mixed disulfide is produced by the oxidation or alkylation of one
of the sulfhydryl groups, rhodanese is inactivated.

Wang and Volini

(1968) used this line of investigation to demonstrate the importance of
the sulfhydryl groups for catalysis.

Their evidence also suggests that

since a rather high concentration of anions, aromatic nitro compounds,
and aliphatic mercaptans inhibit rhodanese activity, one of the essential
groups at the

rhodane~e

active site is aromatic.

rn 1976

B~illie

and

Horowitz concluded that tryptophan residues are essential for activity
from their kinetic inhibition studies using N-1-4-pyridyl-pyridium
chloride, N-methyl-nicotinamide chloride, and nicotinamide.
As a result of these studies employing inhibiting and inactivating agents, Westley (1973) has postulated the presence of three essential parts of the rhodanese active site.

These are a sulfhydryl group,

a cationic group, and a hydrophobic area.

Wang and Volini (1968) con-

cluded that these groups are close to one another spatially, "since
blocking with either a thiosulfate-competitive anion or a thiosulfatecompetitive aromatic protects the essential sulfhydryl group from attack,
as does blocking with thiosulfate or with just the transferable sulfane
sulfur itself." (Westley, 19731

9

Other characteristics of the enzyme have been elucidated including recently, its complete amino acid sequence.

Sorbo (1953} was the

first to crystallize rhodanese and determine its molecular weight,
approximately 37,000.
approximately 8.6.
(Westley, 1973}_,

Its optimum pH has been widely accepted to be

No prosthetic groups have ever been discovered
Several investigators including Volini, et al. (1967},

and Bolen and Rajender (1974) have tried to determine whether a zinc ion
is bound to rhodanese and is necessary for either structural integrity
or catalytic activity.

It is especially difficult to draw any conclu-

sions because all the substrates complex with metal ions except the
thiosulfonates and because of the obvious difficulty of ridding all
glassware, solutions, etc. from trace ions.

Bolen and

~jender

concluded

that, "commercial rhodanese binds zn++ with moderate to weak affinity by
a process that is entropy driven."
In the last several years much sequence analysis of the active
site has been done.

DeToma and Westley (19701, Blumenthal and Heinrikson

(19721, and Cannella, et al. (1973L have independently determined the
amino acid s.equence around the reactive cysteinyl residue of rhodanese.
Concurrently, Heinrikson and Russell (19721 published their findings on
the sequence analysis of the tryptic peptides containing tryptophan.
During this time, however, a controversy had arisen concerning the
molecular weight of rhodanese.

'A mobile monomer-dimer equilibrium

(Volini, DeToma and Westley, 196 7 L was proposed and subsequently confirmed by Horowitz and Westley (1970}.

The monomer was suggested to

have a molecular weight of 19,000, to be identical subunits, to have
one active site, and to aggregate in a pH-dependent reaction into the
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dimer by a disulfide bond between the nonactive site crysteines.

They

maintained that dissociation of the monomers occurs at a high pH, while
at a pH of 7 a stable dimer-monomer equilibrium exists.

In the last two

years, however, Ellis and Woodward (19751, Bergsma, Hol, et al. (1975),
Russell, Weng et al.

(1975), and Crawford and Horowitz (1976) have inde-

pendently done extensive investigations resulting in data inconsistent
with the presence of any monomeric species.

Their evidence appears to

have been accepted.
Finally, the complete sequence analysis of rhodanese has recently
been worked out (Russell, Weng, et al., 1975).

This evidence indicates

that rhodanese is a single polypeptide of molecular weight 35,200.
The biological distribution of rhodanese is of major imJ?ortance
to this investigation.

Lang (1933l found rhodanese present in birds,

frogs, E. coli, and in all mammalian tissues investigated except blood
and muscle.

He demonstrated the wide variety of activity levels of rho-

danese among various tissues.
Gemeinhardt U939) first determined rhodanese activity in plants,
and others later followed.

Tomati,

~

al.

(19721 recently detected low

levels of activity in the chloroJ?lasts of spinach, turnips, parsley, and
cabbage.

Himwich and Saunders (19501 studied a wide variety of mammalian

tissues.

The results correlated well with Lang's, but Himwich reported

low levels of rhodanese in muscle tissue.

Sorbo (1951) also reported

rhodanese activity in a wide variety of tissues, and his results confirmed
the earlier reports.

F;rom these investigations, the liver and adrenal

glands appear to have the highest levels of activity, with moderately
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high levels appearing in the kidneys, and lower levels in other tissues.
In 1955, deDuve, Pressman, et al. studied the subcellular distribution
of rhodanese and reported the enzyme to be confined exclusively to the
mitochondrion.

In 1975, Koj, et al. investigated not only the intra-

cellular but the intrarnitochondrial activities of rhodanese, in rodent
liver, and the results were as follows, with mean rhodanese activity
expressed as micromoles

seN-

formed during five minutes incubation at

whole homogenate

=

9.25

nuclear fraction

=

15.31

mitochondrial fraction

=

22.23

lysosomal fraction

==

5.57

microsomal fraction

=

0.29

final supernatant

=

0.95

outer membrane

=

163

=

2,3%

inner membrane

=

117

=

1.6%

interrnembrane

;:::

969

=

13.3%

matrix

=

6021

=

82.8%

For the intrarnitochondrial fraction:

(Koj, Frendo, and Wojtczak, 1975)
Thus, rhodanese appears to be nearly ubiquitous, but as yet, the
primary function of the enzyme remains unknown.

A role in the detoxi-

fication of cyanide was believed to be its most important function for
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a long time, but this does not seem to account for the high activities
found in the liver (Westley, 1973}. ,

Another possible action is the

neutralization of the sulfide formed by cysteine degradation.

L-cysteine

H2S + NH 3 + pyruvate

cysteine
"
desulfhydrase

"
cystine + H2S +

so 3

rhodanese
........

(Koj, Frendo, 19621
Koj and Frendo (1962)_ measured activities of rhodanese and cysteine
desulfhydrase in various tissues to investigate a possible correlation,
but their results were inconclusive.

Other possible functions include

the transfer to reduced sulfur (.Koj, 1967} and a ,J?Ossible redox role

CWang and Volini, 19681, but the results are also not clear.
Krebs maintains that the major role of rhodanese is in the detoxification of CN- (.19701.

Over thirty years ago he proposed that

nitrilosides, commonly found in many plants, indirectly have an antitumor effect.

He believes that western society is experiencing an

increasing incidence of cancer because it is a vitamin deficiency disease and man has eliminated nearly all of the nitriloside-containing
foods from his diet.

He postulates that the mechanism of action of the

nitrilosides, particularly amygdalin, or laetrile, is as follows.
Laetrile enters the body by foodstuffs and is hydrolyzed by the enzyme
beta-glucosidase, a lysosomal enzyme, "produced by intestinal bacteria
as well as by the body."

(Krebs, 1970,}
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beta-glucosidase

lq

amygdalin (or laetrile)

00

benzaldehyde

+

+

glucose

'>

water
HCN

+

hydrocyanic acid

Accordingly, the released HCN is then detoxified by rhodanese to form
thiocyanate.

Krebs maintains that all normal tissues of the body pro-

duce rhodanese, but neoplastic tissue does not exhibit rhodanese activity because of the inhibiting effects of chorionic gonadotropin produced
by the neoplastic tissue (Krebs, 19771,

As a result, it is selectively

attacked by the CN- •
In 1952 Gal, et

~

measured rhodanese activities in various

normal tissues and cancerous ones of mice and rats.

They concluded

that, "The tumors do not have less rhodanese content than their homologous tissues_ or of some of the vital organs."
Because of the significance of these findings, however, a reinvestigation of rhodanese activity in normal and tumorous tissues is
indicated, and has been undertaken.

MATERIALS AND METHODS
I.

Animal Model and Care
Five-week old male mice, strain BALB/cJ (Jackson Laboratory, Bar

Harbor, Maine) were the animals used throughout this investigation.
Because of the unusual aggressiveness of the males, animals were
maintained in separate false-bottom cages which were properly labeled.
t

They received Purina Standard Mouse Chow and tap water ad libitum.

Humid-

ity in the animal room varied between 35%-55%, temperature varied between
69 -74° F, the photoperiod was twelve hours of light and twelve hours of
darkness, and soft background music was played continuously.
II.

Tumor Transplant Technique
The tumor, an axillary sarcoma, #sl80 (Jackson Laboratory) arose

spontaneously in a white mouse in 1914 in the Croker Laboratory at
Columbia University.

It was isolated and has been used for transplanta-

tion ever since.
The tumor transplant technique is a modification of the procedures
·described by Jackson Laboratory (1975} and I. J. Fidler, et al. (1974).
All equipment was sterile, and aseptic technique was observed.
The tumor donor animal was killed by cervical dislocation and the
tumor immediately ;removed.

Note, the tumor from one donor animal was

adequate for the transplantation procedure.
14

All skin, muscle, and

15
necrotic tissues were separated and the neoplastic tissue placed into a
Petri dish containing cold, sterile, mouse Ringer's solution (Locke's
solution:

9.0 g NaCl, 0.2 g cac1 2 (anhydrous), 0.2 g NaHC0 3 , 2.5 g

glucose, and 0.4 g KCl per liter of solution),

The neoplastic tissue

was then pressed through a 50-mesh tissue sieve with a glass pestle.

As

the droplets fell from the sieve they were collected in the bottom half
of a Petri dish containing 5.0 ml. chilled, sterile, mouse Ringer's
solution.

The resultant cloudy red suspension was mixed by swirling,

placed on ice and covered with the top half of the Petri dish.

Each

recipient mouse was fully anesthetized individually with ether, placed
ventral side up, and the upper and lower right quadrants swabbed with a
sterile alcohol sponge.

Q.S ml. o;l; the tumor cell suspension was then

injected subcutaneously with a 22 gauge, 1-1/2" needle into the right
axillary region.

Control animals were similarly anesthetized and in-

jected with 0.5 ml. of sterile, chilled, mouse Ringer's solution.
During each tumor transplantation there were nine experimental animals
(receiyed the suspended tumor cellsL and six control animals (received
the Ringerls solution},

In this fashion from each transplantation three

experimental animals were used to maintain the tumor and the six controls
and the six experimentals were used in the rhodanese studies.
After the tumor transplant, instruments and equipment were soaked
in Benz-all, an anti-rust, antiseptic agent (Xttriua Laboratory, Chicago,
Illinoisl, scrubbed with soap, rinsed twelve times in tap water, ten
times in distilled water, and six times in distilled deionized water,
then autoclaved.

Needles and syringes were discarded,

16

III.

Tissue Isolation and Homogenization

Materials and reagents are listed in Table I in the Appendix.
Each mouse was killed by cervical dislocation.

The tissues were

rapidly removed and placed in 5.0·ml. ·of 4° C Tris-HCl buffer, pH 7.4.
During the dissection the body cavity was bathed in cold mouse Ringer's
solution.

Four whole brains, four kidneys, one liver, and the back,

thigh, and leg muscles from three animals were pooled for each respective tissue assay.

Only neoplastic tissue was used for the tumor tissue

assay; however, the number of tumors used for each assay varied between
four to seven depending upon the mass of the neoplasms.
After isolation, all tissues except the muscle were homogenized
with three up and down strokes in the 5. 0 ml. of cold Tris buffer.

The

muscle tissue was first minced into small pieces which were homogenized
individually in 5.0. ml. of 4° C Tris buffer.

This modification yielded

complete homogenization.
Tissues were next transferred to chilled centrifuge tubes and

,

spun at 20,200 X g. for ten minutes.

The supernatant was transferred to

a 20 cc. chilled vial, capped, quick-frozen with Cryokwick spray, and
stored frozen.

Within three weeks the supernatant prepared above was

analyzed for rhodanese activity.

IV.

Protein Assay
Protein was determined according to the Lowry technique (1951).

See the Appendix under Protein Assay for the procedure, materials and .
reagents, standard curve, and calculations.
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V.

Enzyme Assay

This technique is a modification of the procedure described by
Bo H. Sorbo (1953) ,

Table III in the Appendix lists the solutions in-

cluding standards and the equipment necessary for the assay.
The following reagents were added to each of seven reaction
vessels:

0.25 ml. of 9.2 M NaH Po 4 , 0.5 ml. of 0.125 M sodium thio2

sulfate, and 0.25 ml. of 0.25 M sodium cyanide.

All seven vessels were

then placed in a 30° C water bath and incubated for ten minutes.

At

staggered time intervals CO, 1, 2, 4, 8, and 16 min.) , 0. 25 ml. of the
tissue supernatant (thawed to 4° C) was added, the solution vortexed,
and the vessel placed back into the water bath.

0.25 ml. of the 1:1

11\i.xture of 0.. 0125 M sodium thiosulfate and 0. 025% serum bovine albumin
was substituted for the enzyme solution in the blank.
reaction mixture was 8.6.

Final pH in this

At the end of the appropriate time interval,

the reaction was stopped by the addition of 0.25 ml. of 38% formaldehyde.
'lbe reaction vessel was once again returned to the water bath.

For the

"O min." the formaldehyde was added to the reaction vessel before the
tissue supernatant.

After all reactions were complete, the vessels were

removed from the water bath.

Ferric nitrate reagent, 1,25 ml., then

12.5 ml. of water were added to each vessel.

These were mixed, trans-

ferred to centrifuge tubes, and spun at 20,200 X g. for 15 minutes to
remove any precipitate.

The percent transmission at 460 nm was then

read and recorded for each.
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The nine crude tissue supernatants (control mouse liver, kidney,
muscle, and brain; and tumor-bearing mouse liver, kidney, muscle, brain,
and tumor) were assayed for rhodanese activity.

Five different samples

of each tissue type were assayed using the six incubation times (0, 1,
2, 4, B, and 16 min.) plus a blank for each assay.

The percent trans-

mission for each of these seven reaction vessels was recorded.
For the standard curve, 0.75 ml. of the given standard solution
was added instead of 0.5 ml. of 0.0125 M sodium thiosulfate and 0.25 ml.
of 0.25 M sodium cyanide.

After three assays were performed, new solu-

tions were prepared and used for the last two assays, as was done in the
preparation of the protein standard curve.

The results between the two

sets of data were then compared :!;or any possible computation or solution
preparation error.
All data obtained were subjected to statistical analysis.
planation of; the statistical analysis, as well as sample data, and
sample calculations are given in the Appendix under "Tissue Assay
Calculations for :Rhodanese and Protein."

'·

An ex-

EXPERIMENTAL DATA
I.

Tumor Transplant
Three days after transplantation tumors were palpable, and

continued to grow until the animal was sacrificed (11 - 16 days) for
the study or expired (25 - 40 days) .

No control animals developed com-

parable tumors.
Histological sections stained with hematoxylin and eosin were
examined by Dr. J, Carter, M,D., pathologist (Louis A. Weiss Memorial
Hospital, Chicago, Illinoisl ,

He confirmed the malignancy of the tumor

and identified it as a histiocytic lymphosarcoma.
II.

Rhodanese Activity Curves for.Each Tissue
Linear regression was performed on the data for each tissue in

order to determine the linearity of the data and the best fit line for
each tissue.

Figures I - V each represent one tissue type studied from

the control and tumor-bearing animals, and show the graph of rhodanese
activity.

Note, the values for the zero-minute readings were subtracted

.from all values as a correction for non-specific catalysis of cyanide to
thiocyanate.

The standard error or standard deviation obtained for each

data point is also plotted.
One unit of rhodanese activity is defined as one micromole of
thiocyanate formed per mg protein.
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III.

Chi Square Analysis
A chi square analysis was then performed in order to determine

whether or not a significant difference in rhodanese activity existed
between:
1.

each tumor-bearing mouse tissue and its corresponding

control tissue
2.

the neoplastic tissue and each analyzed tumor-bearing

mouse tissue.
Table I lists these analyses.
IV.

Comparison of One-minute Specific Activity Values for Tissues
Studied
Figure VI is a bar graph comparing one-minute rhodanese specific

activity values for the tissues investigated from normal and tumorbearing mice.

Standard deviations are plotted for the liver tissues

and standard error for the other tissues studied.

FIGURE I - RHODANESE ACTIVITY CURVE FOR CONTROL AND TUMOR-BEARING
MOUSE LIVER TISSUES
Liver tissue had the highest rhodanese activity of all tissues
studied.

Its activity in normal.

mic~

was found to be significantly

lower (chi square = 0. 05 level) \vhen compared to that from tumor-bearing
mice.
On the graph, tumor-bearing mouse liver tissue is plotted with a
dotted line and that from the normals with a solid line.
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FIGURE I
RHODANESE ACTIVITY CURVE FOR CONTROL
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FIGURE l i - :RHODANESE ACTIVITY CURVE FOR CONTROL AND TUMOR-BEARING
MOUSE KIDNEY TISSUES

.

Kidney tissue had moderately high rhodanese levels when compared
to the other tissues investigated.

Its activity was significantly lower

than that in liver, but significantly higher than brain, muscle, or
neoplastic tissue activity levels.

No significant difference was found

between the activities of normal and tumor-bearing mouse kidney tissues.
Tumor-bearing mouse kidney tissue rhodanese activity is plotted
· • with a dotted line and that from the normals with a solid line.
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FIGURE II
RHODANESE ACTIVITY CURVE FOR CONTROL
AND TUMOR-BEARING MOUSE KIDNEY TISSUES
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FIGURE III - RHODANESE ACTIVITY CURVE FOR CONTROL AND TUMOR-BEARING
MOUSE BRAIN TISSUES
Brain tissue had significantly lower levels of rhodanese activity
than kidney and liver tissues.
of muscle and tumor tissues.

However, the activity was equal to that
No significant difference was found be-

tween the rhodanese activities of the control mouse brain tissue and
that from the tumor-bearing animals.
Tumor-bearing mouse brain tissue is plotted, with a dotted line and
that from the normals with a solid line.
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FIGURE III
RHODANESE ACTIVITY CURVE FOR CONTROL
AND TUMOR-BEARING MOUSE BRAIN TISSUES
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FIGURE IV - RHODANESE ACTIVITY CURVE

~OR

CONTROL AND TUMOR-BEARING

MOUSE MUSCLE TISSUE
Muscle tissue had significantly lower levels of rhodanese activity
than kidney and liver tissues.
of brain and tumor tissues.

However, the activity was equal to that

No significant difference was found between

the rhodanese activities of the control mouse muscle tissue and that from
the tumor-bearing animals.
Tumor-bearing mouse muscle tissue is plotted with a dotted line
and that from the normals with a solid line.
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FIGURE IV·
RHODANESE ACTIVITY CURVE FOR CONTROL
AND TU.HOR-BEARING MOUSE MUSCLE TISSUES
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FIGURE V - RaODANESE ACTIVITY CURVE FOR TUMOR-BEARING MOUSE
TUMOR TISSUE
Neoplastic tissue had significantly lower levels of rhodanese
activity than kidney and liver tissues.

However, the activity was

equal to that in brain and muscle tissues.
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FIGURE V
RHODANESE ACTIVITY CURVE FOR
TUMOR-BEARING l-10USE TUMOR TISSUE
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TABLE I

This table lists the chi square analyses of:
A.

Rhodanese activity between tumor-bearing mouse tissue and its corre-

sponding control tissue, and B.

Rhodanese activity between neoplastic

tissue and selected tumor-bearing mouse tissues.

No significant differ-

ences were found when the tumor-bearing mouse kidney, muscle, and brain
tissues were compared to their corresponding control tissues.

However,

when the liver tissue activities were compared, the liver from tumorbearing mice had a significantly higher activity than that in liver from
the control animals.
The neoplastic tissue had significantly lower activity than that
found in liver and kidney tissues.

However, its activity was not statis-

tically different from that found in brain and muscle tissue.

TABLE I

A.

A Comparison of Rhodanese Activity Between Tumor-Bearing
Mouse Tissue and Its corresponding Control Tissue

Tissues compared

Significance

Chi Square value

liver

3.9060

yes - 0.05 level

kidney

3.3767

none

brain

0.2335

none
' '

muscle

B.

0.3492

none

A Comparison of Rhodanese Activity Between Neoplastic
Tissue and Selected Tumor-Bearing Mouse Tissues

Neoplastic Tissue Compared to:

Chi Square Value

Significance

liver

43.4304

0.005

kidney

14.8050

0.005

brain

0.1893

none

muscle

1.1692

none
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FIGURE VI - A COMPARISON OF ONE-MINUTE RHODANESE SPECIFIC ACTIVITY
VALUES FOR SELECTED TISSUES FROM NORMAL AND TUMOR-BEARING MICE
This table summarizes the relative one-minute rhodanese specific
activities of the tissues studied.

It can be seen that liver tissue has

the highest activity, with kidney tissues showing moderately high activities, and the muscle, brain, and tumor tissues having lower activities that are equal to each other statistically.

Note that the liver

tissue from the tumor-bearing mouse had statistically higher activity
than that from the control mouse.

Standard deviations are plotted for

the liver tissues and standard error for the other tissues studied.
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FIGURE VI
A COMPARISON OF ONE-MINUTE RHODANESE SPECIFIC ACTIVITY
VALUES FOR SELECTED TISSUES FROM NORMAL AND TUMOR-BEARING MICE
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T.

DISCUSSION

From the experimental results (see Figures I - VI}_ it can be seen
that rhodanese has a wide range of activity among various body tissues.
The results obtained correlated well with those of earlier studies.
1933, Sorbo, 1951, and Gal, Fung, and Greenberg, 1952}.

(Lang,

Gal and his asso-

ciates assayed rhodanese activity in a spontaneous tumor (hepatoma produced
by azo dye feeding}_ in rats, a myeloid leukemia (Bar Harbor Gl498l in rats,

and three transplanted mouse carcinomas and one sarcoma.
rhodanese activity was present in the tumors.

In all cases

They concluded that, "While

the rhodanese content of tumors, in general, is !;>mall, j.t is by no means

inconsequential in comparison to other metabolically active tissues."

Al-

though this conclusion conflicts with the Krebs hypothesis, Gal and his
associates also studied female rodents.

Rhodanese activity in the tissues

assayed was similar to that in males except during pregnancy.

It was

interesting to note that the enzyme activity values of liver and kidney
in pregnant females were both lower than that found in the normal controls.
This is consistent with the Krebs hypothesis that chorionic gonadotropin
inhibits rhodanese activity (1977L
Studies of the anti-tumor activity of laetrile were done by Laster
and Schabel (19751 and Nodinsky and Swiniarski (1975}..

In both investi-

gations low concentrations of amygdalin (laetrile} were administered alone
and in combination with beta-glucosidase.

They concluded that amygdalin

alone had no effect, but in combination with beta-glucosidase it was
35
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highly toxic.

A closer examination revealed that the highest dose of

amygdalin administered was only 500 mg/kg body weight.

Other.studies

have shown (Manner, DiSanti, and Michaelson, 1977)_ that doses up to
4000 mg/kg daily are non-toxic.

Krebs maintains that high doses are

necessary for anti-neoplastic activity (19771.
One of the major obstacles to laetrile therapy is the proposed
toxicity of the cyanide ion.

The present investigation demonstrates the

ubiquity of rhodanese in all tissues studied, which provides a mechanism
for the detoxification of cyanide by conversion to thiocyanate.

This

supports the research of Atkinson, Rutter, and Sargeant (1974) in which
rhodanese was an effective antidote for experimental cyanide poisoning.
The :r;>resence of rhodanese activitJ' in the tumor raises questions regarding the efficacy of laetrile to kill cancer cells.

According to Krebs,

it is because of a lack of rhodanese that neoplastic tissue is a direct
target of the cyanide released from the hydrolyzed laetrile.

However,

Sorbo (19531 has shown that rhodanese is not cyanide specific and that
most thiophilic anions serve competitively in this capacity.

Another

weak spot in the Krebs postulate is his assumption that thiosulfate is
present as a sulfur donor.

Volini, DeToma, and Westley (1966, 19671 have

found relatively low levels of thiosulfate in vivo, while other sulfanecontaining compounds are conunonly given off in reactions involving protein metabolism.

Westley (19731 has demonstrated that the enzyme com-

bines with a variety of sulfane-containing anions forming the sulfursubstituted rhodanese.

This correlates with the findings of several

workers (Sorbo, 1962, Hintel and 't"lestley, 1966 }_ whose data assigns
rhodanese the task of a general sulfane transferase.
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The results of this study suggest that laetrile may not work
by the biochemical rationale put forth by Krebs.

It must be emphasized,

however, that this data conflicts with the Krebs hypothesis only on the
activity of rhodanese in neoplastic tissue.
not spontaneous but transplanted.

However, the tumor used was

It is possible that the observed

palliative effects of laetrile may by the result of varying betaglucosidase activity levels, enzyme solubilities, and relative free
enzyme activities in vivo.

SUMMARY

Rhodanese activity was determined spectrophotometrically in
supernatants from crude tissue homogenates of selected tissues isolated from male mice (strain BALB/cJ, Jackson Laboratory, Bar Harbor,
Maine) with transplanted axillary sarcomas.

The control group in-

cluded male mice of the same strain injected with mouse Ringer's
solution (Locke's solution, the vehicle).

Enzyme activity was high

in the liver, with kidney showing moderate activity, and brain and
muscle tissues having lower activity.

A significant increase in the

activity of tumor-bearing mouse liver tissue as compared with that
from normal controls was also noted.

The tumor tissue, which has

been postulated to be devoid of rhodanese activity, was found to
activity equal to brain and muscle tissue.
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TABLE I

MATERIALS AND REAGENTS FOR THE TISSUE ISOLATION AND HOMOGENIZATION
plastic centrifuge tubes
refrigerated centrifuge - Sorvall S·uperspeed RC2-B - automatic
refrigerated centrifuge (Sorvall, Inc., Newtown, Conn.)
tissue homogenizer
coarse forceps
angle-edged scissors
Buffer:
0.158% Tris:HCl, pH= 7.6
12.5 mmole/liter Na s o
2 2 3
100 mmole/liter glycine
1 mi./liter Triton X - 100
NOTE:

All chemicals were obtained from Sigma Chemical Co., St. Louis,
Mo.

Cryokwick (Damon/IEC Division, Needhan Hgts., Mass.)
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PROTEIN ASSAY

This technique is a modification of the procedure described by
Oliver R. Lowry, et al.

(1951I,

Solutions including standards and the

equipment necessary for the assay are listed in Table II.
3.5 ml. of Reagent C was added to 0.7 ml. of the unknown protein
solution or standard.
the blank.

Water was substituted for the protein solution in

After vortexing, this solution was allowed to stand at room

temperature for a minimum of ten minutes.

Next 0.35 ml. of Reagent E

was added very rapidly and the solution vortexed.

After a minimum of 30

minutes, the sample was diluted with 36.4 ml. of water.

The percent

transmission was then read at 500 run in a Bausch and Lomn "spectronic 20"
spectrophotometer and recorded.
NOTE:

When the standard curve was being prepared, three assays

we:r:e performed, then all solutions were discarded.
prepared and used for the last two assays.

New solutions were

The results between the two

sets of data were then compared for any possible computation or solution
preparation error.
Figu:r:e ! is the standard curve for protein, absorbance
density, O.D.l vs. concentration.

~ptical

The points on the curve represent the

best fit points derived by linear regression using the mean absorbance of
each of the protein concentrations chosen.

The standard deviation of the

experimental values for each point is also shown.
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•

The following is the equation of the line derived by linear
regression.

It was used to calculate all experimental protein

concentrations.
X

=

(57 .1429) Y - • 0005
.OD12

where 57.1429. represents the dilution factor obtained as
follows:
57.1429 = 5.0 (36.4)
0.7 4.55

5.0

= total supernatant volume

0.7 = sample of supernatant volume measured
36.4 = ml. of water added to each reaction vessel
4.55 = total volume in reaction vessel.

Table rii shows the linear regression values for the protein
standard curve.

This standard curve is well within experimental error

and was used as the basis for measuring all activity assays.
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TABLE II

Solutions:
Reagent A:
2% Na

2

co 3

Reagent B:
0.5% Cuso

in 0.1 N NaOH

4

• 5 H o in 1.0% sodium potassium tartrate
2

Reagent C:
50.0 ml. of Reagent A are mixed with 1.0 ml. of Reagent B.
This solution is discarded after one day.
Reagent E:
Dilute .Folin-Ciocalteau reagent 1:1 with water.
Standard Solutions:
The following standard solution concentrations were used to
prepare the standard protein curve and were made from
crystalline bovine serum albumin dissolved in water. The
listed concentrations were contained in 0.7 ml. of solution.
100 micrograms of crystalline bovine serum albumin I 0.7 ml.
75 "

so "
25 "

10 "
5 "
NOTE:

All reagents were obtained from Sigma Chemical Company, St.
Louis, Mo.

Equipment:
Bausch and Lomb "spectronic 20"
vortex
electric timer
50 ml. beakers or Erlenmeyer flasks
1 mi. pipettes
5 ml. pipettes
10 ml. pipettes
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FIGURE I

PROTEIN STANDARD CURVE
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TABLE III

LINEAR REGRESSION VALUES FOR PROTEIN STANDARD CQRVE

THEORETICAL Y

X

ACTUAL Y

2.5 micrograms

0.0035

0.0052

5.0

0.0065

0.0068

II

10.0

II

0.0124

0.0126

25.0

II

0.0302

0.0288

so. 0

II

o. 0599

0.0574

75.0

II

0.0895

0.0921

0.1192

0.1188

100

II

a 0 = 0.0005

a

1

= 0.0012

best fit (r 2 )

s
s

0

0.09987

= 0.0008

y·x

=

0.0017

sl = 0

51

THIOCYANATE STANDARD CURVE FOR RHODANESE ACTIVITY
Equipment and reagents used for the rhodanese assay are listed in
Table IV.
Figure II is the standard curve for the enzyme reaction product,
thiocyanate, and shows absorbance (optical density, or O.D.} vs. concentration.

The points on the curve represent the best fit points derived

by linear regression using the mean absorbance of each of the thiocyanate
concentrations chosen.

The standard deviation of the experimental values

for each point is also shown.
The following is the equation of the line derived by linear regression.

It was used to calculate all experimental thiocyanate

concentrations.
X

=(Y .,. .0028\
383. 9J.

I

90.90909

where_ 9-0.90909 = 5.0 (12.50)
-

.25

represents the dilution

2.75

factor obtained as follows:
5.0 = total supernatant volume
.25 = sample of supernatant volume measured
12.50 = ml. of water added to each reaction vessel
2.75 =total volume in reaction vessel.
Table V shows the linear regression values for the thiocyanate
standard curve.

This standard curve is well within experimental error

and was used as the basis for measuring all activity assays.
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TABLE IV

EQUIPMENT AND REAGENTS FOR RHODANESE ASSAY

Solutions:
0.0125 M Na S 0

2 2 3

0.025% serum bovine albumin (crystalline was used)
0.125 M Na S 0

2 2 3

0.2 M NaH Po (buffered to pH
2 4

=

8.6)
\

j

0.25 M NaCN
Ferric Nitrate reagent: 100 g Fe(N0 )
3 3
s.g. 1.40, and H o to 1 liter
2

~9

H o
2

+ 200 ml. HNO ,
3

38% formaldehyde
1:1 mixture of 0.0125 M Na S 0

2 2 3

and 0.025% serum bovine albumin

Standard Solutions:
0. 01 M NaSCN
0.005 M NaSCN
0.001 M NaSCN
0.0005 M NaSCN
Equipment:
Bausch and Loeb "spectronic 20"
30° C water bath
vortex
electric timer
25 ml. Erlenmeyer flasks and/or 20 ml. test tubes
1 ml. pipettes
5 ml. pipettes
10 ml. pipettes
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FIGURE II

THIOCYANATE STANDARD CURVE
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1.0

TABLE V

LINEAR REGRESSION VALUES FOR THE THIOCYANATE STANDARD CURVE

Actual y

Theoretical y

0000 mmole

0.0028

0000

0.00010 "

0.0412

0.0419

0.00025 "

0.0988

0.1076

0.0005 "

0.1947

0.1858

0.001 "

0.3867

0.3889

X

-

-

a

0

= 0.0028

al = 383.9122
best fit (r2)
sl

= 9.4567

s

= 0.0049

s

0

y·x

= 0.0076
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TISSUE ASSAY CALCULATIONS FOR RHODANESE AND PROTEIN

The nine crude tissue supernatants (control mouse
muscle, and brain; and

tumor-bea~ing

live~,

kidney,

mouse liver, kidney, muscle, brain

and tumor) were assayed for rhodanese activity.

Five different samples

of each tissue type were assayed using the six incubation times (0, l,
2, 4, 8, and 16 min.r plus a blank for each assay.

The percent trans-

mission for each o:f these seven reaction vessels was recorded.

This

gave a total of 7 vessels X 5 assays ::: 35 individual readings plus 1
protein determination for each assay = 40 readings for each of the nine
tissues.
1.

With this data the following calculations were performed.
Tlie percent transmissions were converted to optical density

(O.D. or absorbance)_ using the formula O.D. ::: - log _ _.1.,___,
% T

This was done

for both protein and enzyme assays.
2.

The O.D. values for the enzyme assays were then substituted

into the best fit {linear regression} equation for the thiocyanate
standard curve as Y, to obtain the X value, or mmoles of thiocyanate.
Similarly, the O.D. value of each protein assay was substituted into the
-best fit Uinear regression) equation for the protein standard curve as
Y, and the X value,
3.

The

g protein, 'was determined.

g of protein value was converted to mg protein by

dividing by 1000, and the mmole of thiocyanate value was converted to
~mole

of thiocyanate by multiplying by 1000.
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4.

Each micromole of thiocyanate value was divided by its

co~re

sponding protein value for:: that particular assay to give micromole
thiocyanate produced per mg protein for each of the seven vessels for
each assay.

Note that this value, micromoles thiocyanate per mg pro-

tein is the measure of rhodanese activity for that assay time for that
tissue. One rhodanese unit is defined as 1 micromole thiocyanate
formed/mg protein/min.
5.

The mean of the five values for each reaction time for each

tissue was
tion.

det~rmined

as well as the standard error or standard devia-

If each assay represented a pooling of one particular tissue type

but from several different animals (this included the assays for kidney,
muscle, brain, and tumor tissuesl, the standard

e~ror

was determined.

If each assay represented tissue from only one animal (liverL then the
standard deviation was calculated.
~

chart of the data for tumor-bearing mouse kidney is given in

Table IV as an example.

It shows the data from the five assays of the

tissue and all calculated values as described above.

Sample calcula-

tions using data from this tissue are given in Table VII,
A chi square analysis was then performed in order to determine
·whether or not a significant difference in rhodanese activity existed
between:
1.

each

tumo~-bea~ing

mouse tissue and its

cor~esponding

control tissue
2.

the neoplastic tissue and each analyzed tumor-bearing

rouse tissue.

TABLE VI

TUMOR-BEARING MOUSE KIDNEY DATA - A SAMPLE OF

DATA COLLECTED AND COMPUTED FOR EACH SELECTED TISSUE

vessel
Reaction
Time

Column
Exp1anation

0 min.

o.

1st
Assay

%T
D.
pmo1e SCN
units

-

%T
1 min.

2 min.

o.

D.
prno1e SCN
units

%T
0. D.
~le SCN

-

units

85.5
0.0680
15.439
1. 2860

2nd
Assay

100
0

3rd
Assay

4th
Assay

93.3
0.0301
6.465
0.5256

99.5
0.0022
0
0

5th
Assay

Mean

Standard
Error

100
0
0.3623

.±. 0.2257

74.9
0.1255
29.055
2.4202

85.7
0.0670
15.202
1.4426

83.5
0.0783
17.878
1.4535

87.9
0.0560
12.598
0.9388

88.3
0.0540
12.124
0.8773

1.4285

+ 0.2463

63.0
0.2007
46.862
3.9035

68.4
0.1649
38.385
3.6425

76.3
0.1158
26.758
2.1754

79.0
0.1024
23.585
1. 7576

70.7
0.1506
34.998
2.5326

2.8023

i.

o. 3729

U1
(X)

%T
4 min.

o.

D.
pmo1e SCN
units

-

52.1
0.2832
66.398
5.5309

44.7
0.3497
82.145
7.7951

56.7
0.2464
57.684
4.6898

65.2
0.1858
43.334
3.2293

65.3
0.1851
43.168
3.1238

4.8738

+ 0.7685

TABLE VI CONTINUED

. 2nd
Assay

Vessel
Reaction
Time

Column
Explanation

1st
Assay

%T
8 min.

o.

25.8
0.5884
138.668
11.551

25.2
0.5986
141.083
13.388

32.8
0.4841
113.970
9.2659

61.5
0.2111
49.325
3.6758

9.6
1.0177
240.325
20.002

15.9
0.7986
188.443
17.882

21.2
0.6737
158.867
12.916

100
i
i
i

100
i
i
i

100
i
i
i

D.
pmo1e SCN
units

-

%T
16 min.

o.

D.
pmole SCN units

%T
blank

Protein
Cone entration

o. D.
JmlOle SCN
units

-

%T

o.

D.
mg protein

55.9
0.2526
12.002

60.0
0.2218
10.538

3rd
Assay

55.1
0.2588
12.300

Mean

Standard
Error

45.7
0.3401
79.871
5. 7798

8.7321

±. 1.6024

58.3
0.2343
54.818
4.0851

23.9
0.6216
146.530
10.604

13.0978

±. 2.5143

100
i
i
i

100
i
i
i

4th
Assay

52.2
0.2823
13.4195

5th
Assay

51.2
0.2907
13.8195
U1

1.0

TABLE VII

SAMPLE CALCULATIONS

1.

eg.

First, the % T was converted to absorbance (optical density
oro. D.).
"0" time, assay #1, from TABLE VI.
0. D.

=~

lo~ __
l_

Convert 85.5% to 0.855, then substitute.

%T

o.

2.

eg.

eg.

4.

- log

O. D.

= 0.680

1
0.855

The 0. D. value was then substituted into the best fit
(linear regression) equation for the thiocyanate standard curve
as Y, to obtain the X value, or mrnoles of thiocyanate.
X

=

0.0028 (90. 90909)
383.91

y -

X =

0.680 - 0.0028 (90. 90909)
383.91

=

0.015439 mmole thiocyanate

X

3.

D.

This value was then converted to micromoles by multiplying by 1000.
0.015439 X 1000

= 15.439

micromoles of thiocyanate

Steps shown above were performed on the corresponding data for
the protein assays. Then micromoles thiocyanate per mg protein
was calculated for each vessel for each assay. See TABLE VI.
Using the value calculated above in #3, divide by mg protein
determined for assay #1.
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TABLE VII - CONTINUED

15.439 micromoles thiocyanate
12.002 mg protein

5.

eg.

micromoles thiocyanate/
mg protein
(or 1.2860 rhodanese units)

= 1.2860

The mean was then determined by adding the micromoles thiocyanate
per mg protein value (rhodanese unit value) for all five assays
of a particular time and dividing by five.

=

The "2" min. time from TABLE VI

=

1.7576 + 2.5326 = 14.0116

3.9035 + 3.6425 + 2.1754 +

2.8023 micromoles thiocyanate per mg

5 assays
protein mean value or rhodanese units mean value or X.

6.

eg.

Standard error was then determined on values that represented
means of means (tissue from more than one animal in each assay).
values from "2" min. column from TABLE VI.

S- =

N~x.1 2

where:

N2 _- ( N - 1)

N = # of samples (here 5)
Xi = sample value

X

5(3.9035)

2

+ (3.6425)

2

+ (2.1754)

2

+ (1.7576)

2

+

5 2 (5-l)

(2.5326)

2

-

(3.9035 + 3.6425 + 2.1754 + 1.7576 + 2.5326)

(denominator shown above)
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2

TABLE VII - CONTINUED

S;c

=+

0. 3729

The standard deviation was used on values that represented means
of one value (when only one tissue was used in each assay).

eg.
where:
N = # of samples
X = sample value
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GLASSWARE AND EQUIPMENT

PREP~TION

All glassware and equipment was soaked, then scrubbed in a solution
of

a detergent (Alconox, Alconox, Inc., N.Y., N.Y.r, rinsed twelve times

in tap water, eight to ten times in distilled water, and six times in distilled deionized water.

When clean and dry, glassware was protected from

dust with a parafilm covering and stored until use .

•
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